Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (261-270 of 927) with videos related to

Pageof 93
Sort By:
Cells|April 3, 2021
The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease ProgressionValérie F E D Smolders, Kirsten Lodder, Cristina Rodríguez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2006
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden miceMarit Westerterp, Caroline C van der Hoogt, Willeke de Haan, et al.
European Heart Journal|May 26, 2009
The current status of interventions aiming at reducing sudden cardiac death in dialysis patientsMihály K de Bie, Bastiaan van Dam, André Gaasbeek, et al.
Diabetology & Metabolic Syndrome|May 26, 2017
Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular diseaseTheodora W Elffers, Renée de Mutsert, Hildo J Lamb, et al.
European Journal of Epidemiology|September 13, 2014
Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam StudyCatherine E de Keyser, Maarten J G Leening, Silvana A Romio, et al.
Journal of Clinical Epidemiology|July 17, 2024
Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysisSteven H J Hageman, Richard A J Post, Frank L J Visseren, et al.
European Heart Journal|June 23, 2017
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP miceChristine Landlinger, Marianne G Pouwer, Claudia Juno, et al.
Current Drug Discovery Technologies|August 24, 2006
Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class APatrick C N Rensen, J C Emile Gras, Eva K Lindfors, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 24, 2005
Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplastySaskia L M A Beeres, Pranobe V Oemrawsingh, Hazem M Warda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP miceJosé W A van der Hoorn, Willeke de Haan, Jimmy F P Berbée, et al.
Pageof 93

Showing results (261-270 of 927) with videos related to

Sort By:
Pageof 93
Cells|April 3, 2021
The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease ProgressionValérie F E D Smolders, Kirsten Lodder, Cristina Rodríguez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2006
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden miceMarit Westerterp, Caroline C van der Hoogt, Willeke de Haan, et al.
European Heart Journal|May 26, 2009
The current status of interventions aiming at reducing sudden cardiac death in dialysis patientsMihály K de Bie, Bastiaan van Dam, André Gaasbeek, et al.
Diabetology & Metabolic Syndrome|May 26, 2017
Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular diseaseTheodora W Elffers, Renée de Mutsert, Hildo J Lamb, et al.
European Journal of Epidemiology|September 13, 2014
Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam StudyCatherine E de Keyser, Maarten J G Leening, Silvana A Romio, et al.
Journal of Clinical Epidemiology|July 17, 2024
Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysisSteven H J Hageman, Richard A J Post, Frank L J Visseren, et al.
European Heart Journal|June 23, 2017
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP miceChristine Landlinger, Marianne G Pouwer, Claudia Juno, et al.
Current Drug Discovery Technologies|August 24, 2006
Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class APatrick C N Rensen, J C Emile Gras, Eva K Lindfors, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 24, 2005
Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplastySaskia L M A Beeres, Pranobe V Oemrawsingh, Hazem M Warda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP miceJosé W A van der Hoorn, Willeke de Haan, Jimmy F P Berbée, et al.
Pageof 93